Anti-virulence strategy of diaryl chalcogenide compounds against Candida albicans infection

References

• Yano J, Peters BM, Noverr MC, et al. Novel mechanism behind the immunopathogenesis of vulvovaginal candidiasis: “neutrophil anergy”. Infect Immun. 2018;86(3):e00684–13. doi: 10.1128/IAI.00684-17
   PubMed Web of Science ®Google Scholar
• Madhani HD, Fink GR. The control of filamentous differentiation and virulence in fungi. Trends Cell Biol. 1998;8(9):348–353. doi: 10.1016/s0962-8924(98)01298-7
   PubMed Web of Science ®Google Scholar
• Brown AJ, Gow NA. Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol. 1999;7:333–338. doi: 10.1016/s0966-842x(99)01556-5
   PubMed Web of Science ®Google Scholar
• Staib P, Kretschmar M, Nichterlein T, et al. Differential activation of a Candida albicans virulence gene family during infection. Proc Natl Acad Sci. 2000;97(11):6102–6107. doi: 10.1073/pnas.110031497
   PubMed Web of Science ®Google Scholar
• Fazly A, Jain C, Dehner AC, et al. Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc Natl Acad Sci. 2013;110(33):13594–13599. doi: 10.1073/pnas.1305982110
   PubMed Web of Science ®Google Scholar
• Graham CE, Cruz MR, Garsin DA, et al. Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc Natl Acad Sci. 2017;114(17):4507–4512. doi: 10.1073/pnas.1620432114
   PubMed Web of Science ®Google Scholar
• Wu S, Wang Y, Liu N, et al. Tackling fungal resistance by biofilm inhibitors. J Med Chem. 2017;60(6):2193–2211. doi: 10.1021/acs.jmedchem.6b01203
   PubMed Web of Science ®Google Scholar
• Wolfmeier H, Pletzer D, Mansour SC, et al. New perspectives in biofilm eradication. ACS Infec Dis. 2018;4:93–106. doi: 10.1021/acsinfecdis.7b00170
   PubMed Web of Science ®Google Scholar
• Noble SM, Gianetti BA, Witchley JN. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat Rev Microbiol. 2017;15(2):96–108. doi: 10.1038/nrmicro.2016.157
   PubMed Web of Science ®Google Scholar
• Nantel A, Dignard D, Bachewich C, et al. Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol Biol Cell. 2002;13(10):3452–3465. doi: 10.1091/mbc.e02-05-0272
   PubMed Web of Science ®Google Scholar
• Kadosh D, Johnson AD. Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: a genome-wide analysis. Mol Biol Cell. 2005;16(6):2903–2912. doi: 10.1091/mbc.e05-01-0073
   PubMed Web of Science ®Google Scholar
• Carlisle PL, Banerjee M, Lazzell A, et al. Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proc Natl Acad Sci. 2009;106(2):599–604. doi: 10.1073/pnas.0804061106
   PubMed Web of Science ®Google Scholar
• Moyes DL, Wilson D, Richardson JP, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature. 2016;532(7597):64–68. doi: 10.1038/nature17625
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Johnson AD. Candida albicans biofilms and human disease. Ann Rev Microbiol. 2015;69:71–92. doi: 10.1146/annurev-micro-091014-104330
   PubMed Web of Science ®Google Scholar
• Hornby JM, Jensen EC, Lisec AD, et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol. 2001;67(7):2982–2992. doi: 10.1128/AEM.67.7.2982-2992.2001
   PubMed Web of Science ®Google Scholar
• Chen H, Fujita M, Feng Q, et al. Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci. 2004;101(14):5048–5052. doi: 10.1073/pnas.0401416101
   PubMed Web of Science ®Google Scholar
• Ramage G, Saville SP, Wickes BL, et al. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol. 2002;68:5459–5463. doi: 10.1128/AEM.68.11.5459-5463.2002
   PubMed Web of Science ®Google Scholar
• Cao YY, Cao YB, Xu Z, et al. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Ch. 2005;49(2):584–589. doi: 10.1128/AAC.49.2.584-589.2005
   PubMed Web of Science ®Google Scholar
• Zhao S, Huang JJ, Sun X, et al. (1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives suppress Candida albicans virulence by interfering with morphological transition. Microbiol Biotechnol. 2018;11(6):1080–1089. doi: 10.1111/1751-7915.13307
   Google Scholar
• Meng L, Zhao H, Zhao S, et al. Inhibition of yeast-to-hypha transition and virulence of Candida albicans by 2-alkylaminoquinoline derivatives. Antimicrob Agents Ch. 2019;63(4):e01891–18. doi: 10.1128/AAC.01891-18
   PubMed Web of Science ®Google Scholar
• Meng L, Sun C, Zhang C, et al. Efficacy of compounds isolated from Streptomyces olivaceus against the morphogenesis and virulence of Candida albicans. Mar Drugs. 2019;17:442. doi: 10.3390/md17080442
   PubMed Web of Science ®Google Scholar
• Song S, Sun X, Meng L, et al. Antifungal activity of hypocrellin compounds and their synergistic effects with antimicrobial agents against Candida albicans. Microbiol Biotechnol. 2021;14(2):430–443. doi: 10.1111/1751-7915.13601
   Google Scholar
• El-Sharief AM, Moussa Z. Synthesis, characterization and derivatization of some novel types of mono- and bis-imidazolidineiminothiones and imidazolidineiminodithiones with antitumor, antiviral, antibacterial and antifungal activities–part I. Eur J Med Chem. 2009;44:4315–4334. doi: 10.1016/j.ejmech.2009.07.019
   PubMed Web of Science ®Google Scholar
• Ilardi EA, Vitaku E, Njardarson JT. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery. J Med Chem. 2014;57(7):2832–2842. doi: 10.1021/jm401375q
   PubMed Web of Science ®Google Scholar
• Patel VM, Schwartz RA, Lambert WC. Topical antiviral and antifungal medications in pregnancy: a review of safety profiles. J Eur Acad Dermatol Venereol. 2017;31(9):1440–1446. doi: 10.1111/jdv.14297
   PubMed Web of Science ®Google Scholar
• Tan Z, Liang Y, Yang J, et al. Site-specific oxidative C-H chalcogenation of (hetero) aryl-fused cyclic amines enabled by nanocobalt oxides. Org Lett. 2018;20:6554–6558. doi: 10.1021/acs.orglett.8b02889
   PubMed Web of Science ®Google Scholar
• Lee KL, Buckley HR, Campbell CC. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia. 1975;13:148–153. doi: 10.1080/00362177585190271
   PubMedGoogle Scholar
• Gimeno CJ, Ljungdahl PO, Styles CA, et al. Unipolar cell divisions in the yeast S. cerevisiae lead to filamentous growth: regulation by starvation and RAS. Cell. 1992;68(6):1077–1090. doi: 10.1016/0092-8674(92)90079-r
   PubMed Web of Science ®Google Scholar
• Maidan MM, De Rop L, Serneels J, et al. The G protein-coupled receptor Gpr1 and the galpha protein Gpa2 act through the cAMP-protein kinase a pathway to induce morphogenesis in Candida albicans. Mol Biol Cell. 2005;16:1971–1986. doi: 10.1091/mbc.e04-09-0780
   PubMed Web of Science ®Google Scholar
• Daniels KJ, Park YN, Srikantha T, et al. Impact of environmental conditions on the form and function of Candida albicans biofilms. Eukaryotic Cell. 2013;12:1389–1402. doi: 10.1128/EC.00127-13
   PubMed Web of Science ®Google Scholar
• Reynolds TB, Fink GR. Bakers’ yeast, a model for fungal biofilm formation. Science. 2001;291(5505):878–881. doi: 10.1126/science.291.5505.878
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Calabrese D, Sanglard D, et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Ch. 2000;44:1578–1584. doi: 10.1128/AAC.44.6.1578-1584.2000
   PubMed Web of Science ®Google Scholar
• Solis NV, Filler SG. Mouse model of oropharyngeal candidiasis. Nat Protoc. 2012;7(4):637–642. doi: 10.1038/nprot.2012.011
   PubMed Web of Science ®Google Scholar
• Chen L, Wang Z, Liu L, et al. Cinnamaldehyde inhibits Candida albicans growth by causing apoptosis and its treatment on vulvovaginal candidiasis and oropharyngeal candidiasis. Appl Microbial Biotechnol. 2019;103:9037–9055. doi: 10.1007/s00253-019-10119-3
   PubMed Web of Science ®Google Scholar
• Konaté K, Mavoungou JF, Lepengué AN, et al. Antibacterial activity against β-lactamase producing methicillin and Ampicillin-resistant Staphylococcus aureus: fractional inhibitory concentration Index (FICI) determination. Ann Clin Microb Anti. 2012;11:18. doi: 10.1186/1476-0711-11-18
   PubMed Web of Science ®Google Scholar
• Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol. 2004;12(7):317–324. doi: 10.1016/j.tim.2004.05.008
   PubMed Web of Science ®Google Scholar
• Homann OR, Dea J, Noble SM, et al. A phenotypic profile of the Candida albicans regulatory network. PLoS Genet. 2009;5(12):e1000783. doi: 10.1371/journal.pgen.1000783
   PubMed Web of Science ®Google Scholar
• Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994;97(4):339–346. doi: 10.1016/0002-9343(94)90300-x
   PubMed Web of Science ®Google Scholar
• Rhodus NL, Bloomquist C, Liljemark W, et al. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren’s syndrome. J Otolaryng. 1997;26:300–305. PMID: 9343767.
   PubMedGoogle Scholar
• Willis AM, Coulter WA, Fulton CR, et al. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med. 1999;16(8):675–679. doi: 10.1046/j.1464-5491.1999.00134.x
   PubMed Web of Science ®Google Scholar
• Lu Y, Su C, Wang A, et al. Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance. PLoS Biol. 2011;9(7):e1001105. doi: 10.1371/journal.pbio.1001105
   PubMed Web of Science ®Google Scholar
• Shareck J, Belhumeur P. Modulation of morphogenesis in Candida albicans by various small molecules. Eukaryot Cell. 2011;10:1004–1012. doi: 10.1128/EC.05030-11
   PubMedGoogle Scholar
• Hnisz D, Bardet AF, Nobile CJ, et al. A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis. PLoS Genet. 2012;8(12):e1003118. doi: 10.1371/journal.pgen.1003118
   PubMed Web of Science ®Google Scholar
• Kunz C, Kuntz S, Rudloff S. Intestinal Flora. Adv Exp Med Biol. 2009;639(4):67–79. doi: 10.1007/978-1-4020-8749-3_6
   PubMedGoogle Scholar
• Heng X, Jiang Y, Chu W. Influence of fluconazole Administration on gut microbiome, intestinal barrier, and immune response in mice. Antimicrob Agents Ch. 2021;65(6):e02552–20. doi: 10.1128/AAC.02552-20
   PubMed Web of Science ®Google Scholar
• Kurihara T, Sakamoto Y, Kimura T, et al. Meisenheimer rearrangement of azetopyridoindoles. VIII. Synthesis and antiviral activities of 12-carbaeudistomin analogs. Chem Pharm Bull. 1996;44(5):900–908. doi: 10.1248/cpb.44.900
   PubMed Web of Science ®Google Scholar
• Marciniec K, Pawelczak B, Latocha M, et al. Synthesis, anti-breast cancer activity, and molecular docking study of a new group of acetylenic quinolinesulfonamide derivatives. Molecules (Basel, Switzerland). 2017;22:300. doi: 10.3390/molecules22020300
   PubMed Web of Science ®Google Scholar
• Xu GF, Song BA, Bhadury PS, et al. Synthesis and antifungal activity of novel s-substituted 6-fluoro-4-alkyl(aryl)thioquinazoline derivatives. Bioorgan Med Chem. 2007;15(11):3768–3774. doi: 10.1016/j.bmc.2007.03.037
   PubMed Web of Science ®Google Scholar
• Empel A, Kisiel E, Wojtyczka RD, et al. Synthesis and antimicrobial activity of sulfur derivatives of quinolinium salts. Molecules (Basel, Switzerland). 2018;23:218. doi: 10.3390/molecules23010218
   PubMed Web of Science ®Google Scholar
• Liu RH, Shang ZC, Li TX, et al. In vitro antibiofilm activity of eucarobustol E against Candida albicans. Antimicrob Agents Ch. 2017;61(8):2707–2716. doi: 10.1128/AAC.02707-16
   Web of Science ®Google Scholar
• Zhong H, Hu DD, Hu GH, et al. Activity of sanguinarine against Candida albicans biofilms. Antimicrob Agents Ch. 2017;61(5):2259–2316. doi: 10.1128/AAC.02259-16
   PubMed Web of Science ®Google Scholar
• Pandolfi F, D’Acierno F, Bortolami M, et al. Searching for new agents active against Candida albicans biofilm: a series of indole derivatives, design, synthesis and biological evaluation. Eur J Med Chem. 2019 [Epub 2019 Jan 9];165:93–106.
   PubMed Web of Science ®Google Scholar
• Reginatto P, Joaquim A, Rocha D, et al. 8-hydroxyquinoline and quinazoline derivatives as potential new alternatives to combat Candida spp biofilm. Lett Appl Microbiol. 2022;74:395–404. doi: 10.1111/lam.13607
   PubMed Web of Science ®Google Scholar
• Braun BR, Johnson AD. TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics. 2000;155(1):57–67. doi: 10.1093/genetics/155.1.57
   PubMed Web of Science ®Google Scholar
• Saville SP, Lazzell AL, Monteagudo C, et al. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryotic Cell. 2003;2:1053–1060. doi: 10.1128/EC.2.5.1053-1060.2003
   PubMed Web of Science ®Google Scholar
• Zheng XD, Wang YM, Wang Y. CaSPA2 is important for polarity establishment and maintenance in Candida albicans. Mol Microbiol. 2003;49(5):1391–1405. doi: 10.1046/j.1365-2958.2003.03646.x
   PubMed Web of Science ®Google Scholar
• Shirtliff ME, Krom BP, Meijering RA, et al. Farnesol-induced apoptosis in Candida albicans. Antimicrob Agents Ch. 2009;53:2392–2401. doi: 10.1128/AAC.01551-08
   PubMed Web of Science ®Google Scholar